Neuberger Berman Group’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.91M | Sell |
9,093
-424
| -4% | -$107K | ﹤0.01% | 1201 |
|
|
2025
Q4 | $2.71M | Sell |
9,517
-87
| -0.9% | -$27.2K | ﹤0.01% | 1097 |
|
|
2025
Q3 | $2.96M | Sell |
9,604
-632
| -6% | -$198K | ﹤0.01% | 1068 |
|
|
2025
Q2 | $3.22M | Buy |
10,236
+2,533
| +33% | +$731K | ﹤0.01% | 1061 |
|
|
2025
Q1 | $2.02M | Buy |
7,703
+1,738
| +29% | +$470K | ﹤0.01% | 1135 |
|
|
2024
Q4 | $1.56M | Sell |
5,965
-168
| -3% | -$42.3K | ﹤0.01% | 1197 |
|
|
2024
Q3 | $1.43M | Sell |
6,133
-40
| -0.6% | -$8.21K | ﹤0.01% | 1200 |
|
|
2024
Q2 | $1.25M | Buy |
6,173
+694
| +13% | +$125K | ﹤0.01% | 1210 |
|
|
2024
Q1 | $939K | Sell |
5,479
-68,747
| -93% | -$12.8M | ﹤0.01% | 1304 |
|
|
2023
Q4 | $16.1M | Buy |
74,226
+3,707
| +5% | +$636K | 0.01% | 668 |
|
|
2023
Q3 | $11.2M | Sell |
70,519
-2,917
| -4% | -$653K | 0.01% | 729 |
|
|
2023
Q2 | $21.2M | Buy |
73,436
+49
| +0.1% | +$14.9K | 0.02% | 605 |
|
|
2023
Q1 | $23.4M | Sell |
73,387
-28,761
| -28% | -$8.53M | 0.02% | 583 |
|
|
2022
Q4 | $30.1M | Buy |
102,148
+1,337
| +1% | +$369K | 0.03% | 524 |
|
|
2022
Q3 | $23.1M | Buy |
100,811
+960
| +1% | +$240K | 0.02% | 580 |
|
|
2022
Q2 | $21.8M | Buy |
99,851
+5,660
| +6% | +$1.29M | 0.02% | 607 |
|
|
2022
Q1 | $25.1M | Buy |
94,191
+852
| +0.9% | +$209K | 0.02% | 621 |
|
|
2021
Q4 | $24.8M | Sell |
93,339
-46,537
| -33% | -$13.5M | 0.02% | 636 |
|
|
2021
Q3 | $39.7M | Buy |
139,876
+15
| +0% | +$4.28K | 0.03% | 521 |
|
|
2021
Q2 | $38.3M | Sell |
139,861
-50
| -0% | -$13.6K | 0.03% | 533 |
|
|
2021
Q1 | $36.5M | Buy |
139,911
+206
| +0.1% | +$55.2K | 0.03% | 524 |
|
|
2020
Q4 | $35.7M | Sell |
139,705
-2,137
| -2% | -$530K | 0.04% | 486 |
|
|
2020
Q3 | $33.5M | Buy |
141,842
+62
| +0% | +$13.1K | 0.04% | 452 |
|
|
2020
Q2 | $27.5M | Buy |
141,780
+521
| +0.4% | +$99.6K | 0.03% | 491 |
|
|
2020
Q1 | $23.4M | Sell |
141,259
-38,310
| -21% | -$7M | 0.04% | 479 |
|
|
2019
Q4 | $30.7M | Sell |
179,569
-28,904
| -14% | -$4.82M | 0.04% | 492 |
|
|
2019
Q3 | $34.4M | Sell |
208,473
-24,496
| -11% | -$3.44M | 0.04% | 458 |
|
|
2019
Q2 | $27.8M | Buy |
232,969
+954
| +0.4% | +$97.8K | 0.03% | 520 |
|
|
2019
Q1 | $22.1M | Buy |
232,015
+37,015
| +19% | +$3.17M | 0.03% | 579 |
|
|
2018
Q4 | $15.5M | Buy |
195,000
+88,000
| +82% | +$7.45M | 0.02% | 633 |
|
|
2018
Q3 | $11.3M | Buy |
+107,000
| New | +$10M | 0.01% | 771 |
|
|
2018
Q2 | – | Sell |
-5,000
| Closed | -$433K | – | 1743 |
|
|
2018
Q1 | $433K | Sell |
5,000
-4,000
| -44% | -$311K | ﹤0.01% | 1378 |
|
|
2017
Q4 | $621K | Buy |
+9,000
| New | +$591K | ﹤0.01% | 1348 |
|
|
2016
Q1 | – | Sell |
-25,200
| Closed | -$953K | – | 1518 |
|
|
2015
Q4 | $953K | Buy |
25,200
+6,500
| +35% | +$219K | ﹤0.01% | 1139 |
|
|
2015
Q3 | $485K | Buy |
+18,700
| New | +$567K | ﹤0.01% | 1285 |
|
|
2015
Q2 | – | Sell |
-30,600
| Closed | -$1.02M | – | 1600 |
|
|
2015
Q1 | $1.02M | Buy |
+30,600
| New | +$1.03M | ﹤0.01% | 1217 |
|
|
2013
Q3 | – | Sell |
-79,500
| Closed | -$2.5M | – | 1652 |
|
|
2013
Q2 | $2.5M | Buy |
+79,500
| New | +$2.25M | ﹤0.01% | 988 |
|
Other funds holding PODD
VCM
VPM
Neuberger Berman Group's PODD Position: Q1 2026 in Review
Neuberger Berman Group reduced its Insulet (PODD) stake by 4.5% in Q1 2026, selling an estimated $107K and leaving 9,093 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1201.
Neuberger Berman Group first reported a position in PODD in Q2 2013 and has held it in 37 quarters since. The position peaked at $39.7M in Q3 2021. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.
- Neuberger Berman Group held 9,093 shares of Insulet worth $1.91M as of Q1 2026.
- Neuberger Berman Group sold 424 Insulet shares in Q1 2026, an estimated $107K.
- Insulet made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1201 holding.
- Neuberger Berman Group first reported a position in Insulet in Q2 2013 and has held it in 37 quarters since.
- Neuberger Berman Group's Insulet position peaked at $39.7M in Q3 2021.
- 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.